Latest News

If you are wondering whether Transcontinental's current share price reflects its underlying value, you are not alone, and this article is built to help you break that question down calmly and clearly. The stock has moved only modestly in the short term, with a 0.5% decline over 7 days and a 1.6% decline over 30 days, while showing a 36.5% return over 1 year, 115.1% over 3 years and 42.7% over 5 years. Recent headlines around Transcontinental have focused on its position in the materials...

Etablissements Maurel & Prom (ENXTPA:MAU) has kicked off FY 2025 with first-half revenue of US$288.6 million and basic EPS of US$0.52, supported by net income of US$103.6 million. The company has seen revenue move from US$412.1 million in 1H 2024 to US$396.3 million in 2H 2024 and then to US$288.6 million in 1H 2025, while basic EPS shifted from US$0.51 to US$0.66 and now US$0.52. This gives investors a clearer view of how the top and bottom line are tracking across recent periods. With...

LCNB (LCNB) closed out FY 2025 with fourth quarter revenue of US$22.3 million and basic EPS of US$0.40, while trailing twelve month figures showed revenue of US$90.1 million and EPS of US$1.63 as the bank reported net income of US$23.0 million over the period. Over recent reporting periods, revenue has moved from US$79.2 million and EPS of US$0.97 on a trailing basis at the end of 2024 to US$90.1 million and EPS of US$1.63 by the end of 2025, highlighting a period where net margins and...

Investors may be wondering if Coloplast at around kr439.80 is starting to look interesting again, or if the current price still feels rich compared to its fundamentals. The share price has recorded a 4.7% decline over the last 7 days, a 10.6% decline over 30 days, an 18.0% decline year to date and a 37.1% decline over 1 year, while the 3 year and 5 year returns sit at declines of 41.9% and 45.6% respectively. These moves come as investors reassess the company against peers in the healthcare...

Gambling.com Group (GAMB) closed FY 2025 with Q4 revenue of US$46.2 million and a basic EPS loss of US$0.77, alongside a trailing twelve month basic EPS loss of US$0.93 on revenue of US$165.4 million. The company has seen quarterly revenue move from US$35.3 million and basic EPS of US$0.23 in Q4 2024 to US$46.2 million with a basic EPS loss of US$0.77 in Q4 2025, while trailing twelve month revenue shifted from US$127.2 million with basic EPS of US$0.85 in Q4 2024 to US$165.4 million with a...

Century Therapeutics (IPSC) just posted FY 2025 results that put revenue at US$109.2 million with basic EPS of US$0.51 for the latest half, against a trailing twelve month profile that still shows a loss, with EPS of US$0.11 and net income of US$9.6 million in the red on US$109.2 million of revenue. Over the past year, the company has reported revenue of US$1.6 million and EPS of US$0.82 in early 2024, then US$4.96 million with EPS of US$0.79 in the second half of 2024, and then the latest...

ProFrac Holding (ACDC) closed out FY 2025 with fourth quarter revenue of US$436.5 million and a basic EPS loss of US$0.79, alongside net income excluding extra items of a US$142.6 million loss. Over the past few quarters, the company has seen revenue move from US$600.3 million and a basic EPS loss of US$0.12 in Q1 2025 to US$403.1 million and a basic EPS loss of US$0.60 in Q3 2025. Trailing twelve month figures show revenue at US$1.9 billion and a net loss of US$369 million, setting up a...

CareCloud (CCLD) has capped FY 2025 with fourth quarter revenue of US$34.4 million and basic EPS of US$0.04, alongside trailing 12 month revenue of US$120.5 million and basic EPS of US$0.10, marking a clean move away from the losses seen earlier in the period. The company has seen quarterly revenue step up from US$27.4 million in Q2 2025 to US$34.4 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.04 in Q1 2025 to positive readings in each subsequent quarter,...

Compagnie de Saint-Gobain (ENXTPA:SGO) has posted its FY 2025 results with second half revenue of €22.6b, basic EPS of €2.54 and net income of €1,254m, against a backdrop of modest earnings growth over the past year and a small uptick in net profit margin to 6.2%. The group has seen revenue move from €23.1b in 2H 2024 to €22.6b in 2H 2025, while trailing twelve month EPS sits at €5.83 on net income of €2,883m. This gives investors a clear read on earnings power heading into the new year. With...

Trinity Capital (NasdaqGS:TRIN) has recently committed growth capital to three MedTech companies: Monteris Medical, Emboline, and Neuros Medical. The financing supports commercialization of Monteris Medical's neurosurgical system, Emboline's heart procedure protection platform, and Neuros Medical's non opioid pain treatment device. These back to back commitments expand Trinity Capital's exposure to advanced medical technologies within its venture lending portfolio. Trinity Capital focuses...

Cathay Pacific Airways (SEHK:293) has reported its FY 2025 first half results with revenue of HK$54.3b and basic EPS of HK$0.57, while trailing twelve month figures show revenue of HK$116.8b and basic EPS of HK$1.66. The company has seen revenue move from HK$49.6b and EPS of HK$0.52 in 1H 2024 to HK$54.3b and EPS of HK$0.57 in 1H 2025, backed by trailing twelve month net income of HK$10.8b. With a trailing net profit margin of 9.3% and passenger load factors in the mid 80% range, this set of...

Aris Mining (TSX:ARIS) just posted its FY 2025 numbers with Q4 revenue of US$308.6 million and basic EPS of US$0.25, alongside trailing twelve month revenue of US$927.7 million, basic EPS of US$0.42 and net income of US$78.3 million. The company has seen revenue move from US$151.1 million in Q4 2024 to US$308.6 million in Q4 2025, while basic EPS went from US$0.13 to US$0.25 over the same period. This gives investors a clear view of how the top and bottom lines are tracking into the current...

Brenntag SE has released its full-year 2025 results, reporting sales of €15,171.50 million and net income of €264.60 million, both lower than the prior year, and announced an annual dividend of €1.90 per share payable in May 2026. The sharp drop in net income and earnings per share from continuing operations highlights pressure on profitability that may prompt investors to reassess Brenntag’s earnings quality and capital return profile. We’ll now examine how Brenntag’s weaker full-year...

Helia Group recently reported strong FY25 results, including higher net profit and a solid capital position, and its shares have now traded ex-dividend ahead of a large final fully franked dividend and a partially franked special dividend that together reflect a 14% cash yield before franking. By fully paying out statutory NPAT while also shrinking its capital base, Helia is leaning heavily into capital return, raising fresh questions about how it balances near-term income for shareholders...

If you are wondering whether Commonwealth Bank of Australia (CBA) is priced fairly or carrying a premium at around A$171.60 per share, you are not alone. Many investors are asking the same question right now. CBA's share price has been relatively steady over the past week with a 0.6% decline, while the stock shows returns of 8.1% over 30 days, 6.5% year to date, 22.6% over 1 year, 99.5% over 3 years and 140.0% over 5 years. Recent news coverage around CBA has largely focused on its role as a...

Americas Gold and Silver (TSX:USA) has entered a joint venture to build a commercial antimony processing facility in Idaho. The company reported new high grade silver copper antimony and silver lead discoveries at its Galena Complex. Management has also launched the largest drilling campaign in the company’s history at Galena. Americas Gold and Silver, trading at CA$10.96, has seen very large share price gains over the past year and over the past three years, while the stock is up 56.6%...

Voyager Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$27.43 million, improving from US$34.49 million a year earlier, while its full-year 2025 net loss widened to US$119.72 million from US$65.00 million in 2024. Although Voyager reduced its quarterly loss per share, the much larger full-year loss highlights the cost intensity of advancing its neurological disease pipeline. We’ll now examine how Voyager’s improved quarterly loss but much larger...

Zurn Elkay Water Solutions (NYSE:ZWS) reported record annual performance with double digit core sales growth. The company highlighted improved operating margins over the year. Management announced a substantial increase in its dividend. The company also disclosed a significant share repurchase program. Zurn Elkay Water Solutions focuses on water management products and systems, an area that sits at the intersection of infrastructure, building construction, and resource efficiency. With...

If you are wondering whether BioNTech's current share price lines up with its long term potential, starting with a clear look at valuation can help you frame that question more calmly. BioNTech's shares recently closed at US$90.10, with returns of 11.6% decline over the past week, 17.3% decline over the last month, and 6.8% decline year to date, alongside 7.6% decline over 1 year, 31.7% decline over 3 years, and 12.2% decline over 5 years, which hints that the market's view on risk and...

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...

Lanson-BCC (ENXTPA:ALLAN) has put fresh numbers on the table, with first half FY 2025 revenue at €92.05 million and basic EPS at €0.28, alongside trailing twelve month revenue of €259.69 million and EPS of €3.31 that frame how the latest stretch compares with the recent run rate. The company has seen revenue move from €87.80 million and EPS of €0.56 in first half FY 2024 to €167.64 million and EPS of €3.03 in second half FY 2024, giving investors a clear look at how top line scale and per...

Basic-Fit (ENXTAM:BFIT) has wrapped up FY 2025 with second half revenue of €743.2 million and basic EPS of €0.34, alongside trailing 12 month revenue of €1.42 billion and basic EPS of €0.22. These figures frame the latest numbers in a broader earnings upswing. The company has seen revenue move from €630.44 million in the second half of 2024 to €743.2 million in the second half of 2025, while basic EPS shifted from €0.06 to €0.34 over the same periods. This sets up a story where higher sales...

Velocity Financial FY 2025 results in focus Velocity Financial (VEL) has wrapped up FY 2025 with fourth quarter total revenue of US$57.1 million and basic EPS of US$0.89, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$84.9 million in Q4 2024 to US$57.1 million in Q4 2025, while basic EPS shifted from US$0.62 to US$0.89 over the same period, and on a trailing twelve month basis EPS stands at US$2.81 on revenue of US$183.5...

Oil-Dri Corporation of America (ODC) has just posted Q2 2026 results with revenue of US$117.7 million and basic EPS of US$0.87, alongside trailing twelve month EPS of US$3.62 on revenue of US$478.9 million. Over recent quarters the company has seen revenue move between US$116.9 million and US$127.9 million, while quarterly EPS has ranged from US$0.80 to US$1.13. This sets up a picture of steady top line and earnings performance that now sits on the back of 15.6% earnings growth over the past...